204 related articles for article (PubMed ID: 24767688)
21. Functional outcomes after treatment for prostate cancer.
Rocco B; De Lorenzis E; Palumbo C
N Engl J Med; 2013 Apr; 368(17):1653. PubMed ID: 23614596
[No Abstract] [Full Text] [Related]
22. Functional outcomes after treatment for prostate cancer.
Resnick MJ; Penson DF
N Engl J Med; 2013 Apr; 368(17):1654. PubMed ID: 23614595
[No Abstract] [Full Text] [Related]
23. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer.
McCammon KA; Kolm P; Main B; Schellhammer PF
Urology; 1999 Sep; 54(3):509-16. PubMed ID: 10475363
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological, functional, and immediate oncologic outcome assessment in men aged≤50 years with prostate cancer after robotic prostatectomy.
Samadi DB; Sebrow D; Hobbs AR; Bernstein AN; Brajtbord J; Lavery HJ; Jazayeri SB
Urol Oncol; 2017 Jan; 35(1):30.e17-30.e24. PubMed ID: 27567690
[TBL] [Abstract][Full Text] [Related]
25. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
Walsh PC
J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
[TBL] [Abstract][Full Text] [Related]
26. Treatment choice and quality of care for men with localized prostate cancer.
Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
[TBL] [Abstract][Full Text] [Related]
27. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
28. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
Penson DF; McLerran D; Feng Z; Li L; Albertsen PC; Gilliland FD; Hamilton A; Hoffman RM; Stephenson RA; Potosky AL; Stanford JL
J Urol; 2005 May; 173(5):1701-5. PubMed ID: 15821561
[TBL] [Abstract][Full Text] [Related]
29. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Koyama T; Albertsen PC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Hoffman RM; Kaplan SH; McCollum D; Paddock LE; Stanford JL; Stroup AM; Wu XC; Penson DF
Eur Urol; 2015 Jun; 67(6):1019-1025. PubMed ID: 25174325
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.
Loeb S; Folkvaljon Y; Robinson D; Schlomm T; Garmo H; Stattin P
Eur Urol; 2016 Nov; 70(5):824-828. PubMed ID: 26743040
[TBL] [Abstract][Full Text] [Related]
31. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract][Full Text] [Related]
32. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
Salomon L; Droupy S; Yiou R; Soulié M
Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
[TBL] [Abstract][Full Text] [Related]
33. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
34. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
35. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
[TBL] [Abstract][Full Text] [Related]
36. Incontinence and erectile dysfunction following radical prostatectomy: a review.
Alivizatos G; Skolarikos A
ScientificWorldJournal; 2005 Sep; 5():747-58. PubMed ID: 16170437
[TBL] [Abstract][Full Text] [Related]
37. Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services.
Cathcart P; Sridhara A; Ramachandran N; Briggs T; Nathan S; Kelly J
Eur Urol; 2015 Jul; 68(1):22-9. PubMed ID: 25770482
[TBL] [Abstract][Full Text] [Related]
38. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
39. Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPRO.
Derogar M; Dahlstrand H; Carlsson S; Bjartell A; Hugosson J; Axén E; Johansson E; Lagerkvist M; Nyberg T; Stranne J; Thorsteinsdottir T; Wallerstedt A; Haglind E; Wiklund P; Steineck G;
Acta Oncol; 2016 Dec; 55(12):1467-1476. PubMed ID: 27684933
[TBL] [Abstract][Full Text] [Related]
40. Time course and predictors of symptoms after primary prostate cancer therapy.
Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
